These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 2324511)

  • 1. A specific, sensitive radioimmunoassay for platelet-activating factor (PAF).
    Smal MA; Baldo BA; McCaskill A
    J Immunol Methods; 1990 Apr; 128(2):183-8. PubMed ID: 2324511
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combining site specificities of rabbit antibodies to platelet-activating factor (PAF).
    Cooney SJ; Smal MA; Harle DG; Baldo BA
    Mol Immunol; 1990 May; 27(5):405-12. PubMed ID: 2366757
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Production of antibodies to platelet activating factor.
    Smal MA; Baldo BA; Redmond JW
    Mol Immunol; 1989 Aug; 26(8):711-9. PubMed ID: 2811869
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of a radioimmunoassay and bioassay for embryo-derived platelet-activating factor.
    Ammit AJ; O'Neill C
    Hum Reprod; 1991 Jul; 6(6):872-8. PubMed ID: 1757528
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production and characterization of antibodies to platelet-activating factor.
    Macpherson JL; Spur B; Pyne SG; Heymans F; Cox MF; Godfroid JJ; Krilis SA
    J Lipid Mediat; 1992 Feb; 5(1):49-59. PubMed ID: 1391739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stability of platelet activating factor (PAF) in human saliva. Quantitation by radioimmunoassay.
    Cooney SJ; Smal MA; Baldo BA
    Clin Chim Acta; 1991 Aug; 200(2-3):161-73. PubMed ID: 1777966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radioimmunoassay for platelet-activating factor.
    Karasawa K; Satoh N; Hongo T; Nakagawa Y; Setaka M; Nojima S
    Lipids; 1991 Dec; 26(12):1126-9. PubMed ID: 1819698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of a novel scintillation proximity radioimmunoassay for platelet-activating factor measurement: comparison with bioassay and GC/MS techniques.
    Sugatani J; Lee DY; Hughes KT; Saito K
    Life Sci; 1990; 46(20):1443-50. PubMed ID: 2111868
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The specificity of the binding of platelet activating factor (PAF) to anti-PAF antibodies.
    Smal MA; Baldo BA; Harle DG
    J Mol Recognit; 1990 Aug; 3(4):169-73. PubMed ID: 1703770
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A specific, sensitive and high-capacity immunoassay for PAF.
    Baldo BA; Smal MA; McCaskill AC
    Lipids; 1991 Dec; 26(12):1136-9. PubMed ID: 1819700
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific binding of antibodies to platelet-activating factor (PAF) as demonstrated by thin-layer chromatography/immunostaining.
    Karasawa K; Satoh N; Hongo T; Nakagawa Y; Setaka M; Nojima S
    Lipids; 1991 Dec; 26(12):1122-5. PubMed ID: 1819697
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Synthesis of a PAF immunogen and production of PAF-specific antibodies.
    Smal MA; Baldo BA; Redmond JW
    Lipids; 1991 Dec; 26(12):1130-5. PubMed ID: 1819699
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Quantitation by radioimmunoassay of PAF in human saliva.
    Cooney SJ; Smal MA; Baldo BA
    Lipids; 1991 Dec; 26(12):1140-3. PubMed ID: 1819701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Production and characterization of specific antibodies against 1-O-alkyl-2-acetyl-sn-glycero-3-phosphocholine (a potent hypotensive and platelet-activating ether-linked phospholipid).
    Nishihira J; Ishibashi T; Imai Y
    J Biochem; 1984 May; 95(5):1247-51. PubMed ID: 6430883
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A facile synthesis of an aldehydic analog of platelet activating factor and its use in the production of specific antibodies.
    Wang CJ; Tai HH
    Chem Phys Lipids; 1990 Sep; 55(3):265-73. PubMed ID: 2289287
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibodies to synthetic platelet-activating factor (1-O-alkyl-2-O-acetyl-sn-glycero-3-phosphocholine) analogues with substituents at the sn-2 position.
    Karasawa K; Satoh N; Masuda M; Setaka M; Hashimoto K; Ishibashi K; Nojima S
    J Biochem; 1991 Nov; 110(5):683-7. PubMed ID: 1723729
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative analysis of platelet-activating factor in human plasma. Application to patients with liver cirrhosis and disseminated intravascular coagulation.
    Sugatani J; Miwa M; Komiyama Y; Murakami T
    J Immunol Methods; 1993 Dec; 166(2):251-61. PubMed ID: 8288878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A competitive receptor binding assay for platelet-activating factor (PAF): quantification of PAF in rat brain.
    Tiberghien C; Laurent L; Junier MP; Dray F
    J Lipid Mediat; 1991; 3(3):249-66. PubMed ID: 1773028
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new method of purification and sensitive bioassay of platelet-activating factor (PAF) in human whole blood.
    Shinozaki K; Kawasaki T; Kambayashi J; Sakon M; Shiba E; Uemura Y; Ou M; Iwamoto N; Mori T
    Life Sci; 1994; 54(6):429-37. PubMed ID: 8295490
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Production of platelet-activating factor by the pre-implantation sheep embryo.
    Battye KM; Ammit AJ; O'Neill C; Evans G
    J Reprod Fertil; 1991 Nov; 93(2):507-14. PubMed ID: 1787472
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.